TJ Bio has reportedly submitted a biologics license application (BLA) to China’s Center for Drug Evaluation for GX-H9 ...

Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...

Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

INR:1292. game bataiye A number of drug companies have withdrawn from the market Remdesivir generic drug approved and priced Novo Nordisk's once-weekly long-acting g ...

The company also makes and distributes Victoza, another diabetes medicine, as well as blood-disorder, growth-disorder and ...